Biography

Ms. Rodriguez has more than 30 years of experience in the biopharmaceutical industry, serving across a broad range of executive leadership roles. Most recently, Ms. Rodriguez served as Chief Commercial Officer of Ardelyx, Inc. from May 2020 to May 2024 where she led the launches of first in class therapies across the gastroenterology and nephrology market spaces, advancing Ardelyx from a discovery and development company to a commercially facing company. From 2014 to 2019, Ms. Rodriguez served as the Chief Executive Officer of Tolmar Pharmaceuticals, Inc., a specialty oncology company, where she established the US commercial entity for the global, family-owned pharmaceutical company, achieving a market leading position for their primary oncology asset, advancing their pipeline, and successfully launching a new product in rare disease. Upon the formation of the global Tolmar entity in 2019, Ms. Rodriguez was named President of the branded pharmaceutical division. From 1990 to 2014, Ms. Rodriguez held various leadership positions at Abbott Laboratories (NYSE: ABT), most recently as Divisional Vice President of Global Marketing, where she led the global marketing and portfolio strategy function for an international portfolio of Abbott products from 2002 to 2006. Prior to this role, Ms. Rodriguez served as the Vice President and General Manager of the Abbott Renal Franchise from 1998 to 2002, where she established a market leading position for Abbott in the injectable vitamin D market with the launch of an innovative next generation therapy. Prior to this, Ms. Rodriguez held a broad range of commercial leadership roles across the neuroscience, cardiovascular, urology, gastroenterology and anti-infective therapeutic areas in the pharmaceutical division as well as at the Abbott – Takeda joint venture – TAP. Prior to joining Abbott, she held sales and marketing roles at Merck, and served as a client manager for a pharmaceutical market research consulting firm. Ms. Rodriguez serves on the board of directors for Veradigm Inc. and Heron Therapeutics. Ms. Rodriguez received an M.S. and B.S. in psychology from the University of Pennsylvania.